Nazem and Company specializes in investments in seed, early, and late stages; follow on financings; and pre-IPO investments.
Nazem and Company is a principal investment firm specializing in investments in seed, early, and late stages; follow on financings; and pre-IPO investments. It seeks to invest in all the stages of the company’s development. The firm also invests in stress and turnaround situations where it can lead reorganization efforts. It seeks to invest in companies in emerging, high-potential growth industries and mature markets. The firm prefers to invest in healthcare services, biotechnology and life sciences, electronics, information technology, telecommunications, and the Internet sectors. It seeks to invest in under-valued, profitable companies around the globe. The firm targets companies based in the United States. Nazem and Company was founded in 1976 and is headquartered in New York, New York with an additional office in Menlo Park, California.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 17, 2004
Bluebird Bio
|
Series A | $8.50M | Biotechnology | — |
Nazem and Company has had 1 exits. Nazem and Company most notable exits include Bluebird Bio
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jun 14, 2019 | Bluebird Bio | IPO | Biotechnology | Detail |